RedDress
1 known investors
RedDress develops autologous wound healing solutions, including its ActiGraft/ActiGraftPro product that uses a patient's own blood to create a blood-derived clot for treating chronic, non-healing wounds. It sells to healthcare providers and clinicians, with products eligible for Medicare reimbursement in the U.S.
BiotechHealthtechMedical Devices
Investors Β· 1
Frequently asked questions
- What does RedDress do?
- RedDress develops autologous wound healing solutions, including its ActiGraft/ActiGraftPro product that uses a patient's own blood to create a blood-derived clot for treating chronic, non-healing wounds. It sells to healthcare providers and clinicians, with products eligible for Medicare reimbursement in the U.S.
- Who are RedDress's investors?
- RedDress's investors include Boston Harbor Angels.